Induction of apoptosis in glioma cells by recombinant human Fas ligand

Neurosurgery

Volumn 46, Issue 2, 2000, Pages 431-439

  Kawaguchi, Shojiro ^a   Mineta, Toshihiro ^a   Ichinose, Makoto ^a   Masuoka, Jun ^a   Shiraishi, Tetsuya ^a   Tabuchi, Kazuo ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Baculovirus; Fas; Fas ligand; Glioma

Indexed keywords

ANNEXIN; COMPLEMENTARY DNA; FAS ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY; RABBIT ANTISERUM; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR; VIRUS VECTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEPIDOPTERA; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; WESTERN BLOTTING;

EID: 0033981674     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200002000-00030     Document Type: Article

References (45)

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH: Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162, 1999.
2. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 377:630-632, 1995.
3. Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F: The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 160:5669-5675, 1998.
4. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 6:79-88, 1997.
5. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/ APO-1- and TNF receptor-induced cell death. Cell 85:803-815, 1996.
6. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798, 1995.
7. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512, 1995.
8. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytoma: A simple and reproducible method. Cancer 62:2152-2165, 1988.
9. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192, 1995.
10. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J, Tschopp J: Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape. Science 274:1363-1366, 1996.
11. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997.
12. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991.
13. Kontny HU, Lehrnbecher TM, Chanock SJ, Mackall CL: Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma. Cancer Res 58:5842-5849, 1998.
14. Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71:826-836, 1989.
15. Mariani SM, Matiba B, Sparna T, Krammer PH: Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system. J Immunol Methods 193:63-70, 1996.
16. Miyamoto C, Smith GE, Farrell-Towt J, Chizzonite R, Summers MD, Ju G: Production of human c-myc protein in insect cells infected with a baculovirus expression vector. Mol Cell Biol 5:2860-2865, 1985.
17. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827, 1996.
18. Nagata S: Apoptosis by death factor: Review. Cell 88:355-365, 1997.
19. Nakagawa S, Shiraishi T, Kihara S, Tabuchi K: Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch 427:175-179, 1995.
20. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075-1082, 1996.
21. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709-10715, 1992.
22. Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S: Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157:2909-2915, 1996.
23. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY: Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? J Clin Invest 99:1173-1178, 1997.
24. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411-415, 1995.
25. Shiraishi T, Nakagawa S, Toda K, Kihara S, Ju Y, Tabuchi K: Anti-Fas antibody induces apoptosis in cultured glioma cells by activation of the sphingomyelin pathway, in Nagai M (ed): Brain Tumor Research and Therapy. Tokyo, Springer-Verlag, 1996, pp 283-291.
26. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959-962, 1994.
27. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: A mechanism of immune evasion? Nat Med 2:1361-1366, 1996.
28. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879, 1994.
29. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 186:2045-2050, 1997.
30. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993.
31. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994.
32. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol 5:1567-1574, 1994.
33. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 2:317-322, 1996.
34. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521, 1997.
35. Toda K, Shiraishi T, Hirotsu T, Fukuyama K, Mineta T, Kawaguchi S, Tabuchi K: The cytocidal activity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas ligand/Fas system. Jpn J Cancer Res 87:972-976, 1996.
36. Toda K, Shiraishi T, Nakagawa S, Kihara S, Ju Y, Tabuchi K: Relationship between Fas antigen expression and apoptosis in glial tumors [in Japanese]. Neuroimmunol Res 7:125-128, 1995.
37. Volm M, Bak M Jr, Efferth T, Lathan B, Mattern J: Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res 8:531-535, 1988.
38. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JCL, Lynch DH: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163, 1999.
39. Walker PR, Saas P, Dietrich PY: Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 158:4521-4524, 1997.
40. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992.
41. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279, 1989.
42. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954-964, 1994.
43. Weller M, Kleihues P, Dichgans J, Ohgaki H: CD95 ligand: Lethal weapon against malignant glioma? Brain Pathol 8:285-293, 1998.
44. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ, Fontana A: Fas/ APO-1 gene transfer for human malignant glioma. Cancer Res 55:2936-2944, 1995.
45. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 196:1747-1756, 1989.